Search

Your search keyword '"Brown VI"' showing total 63 results

Search Constraints

Start Over You searched for: Author "Brown VI" Remove constraint Author: "Brown VI"
63 results on '"Brown VI"'

Search Results

2. A narrative review of economic constructs in commonly used implementation and scale-up theories, frameworks and models

3. Survey of traffic noise reduction products, materials, and technologies

5. Survey of traffic noise reduction products, materials, and technologies

6. Liquidity Myths.

7. Medical isotope collection from ISAC targets

8. A Segregation of Memory: The 1921 Tulsa Race Riot.

9. Talent Management Admiring America's Most Admired Companies.

10. An African American Pioneer: Charles W. Pierce, B.S.ChE, 1901.

11. CELEBRATING: Black History, Careers and Diversity.

12. RAISING THE STAKES in High Technology at the Department of Commerce.

13. A cost evaluation of cross-border truck emissions testing using heavy duty remote sensing equipment : final report 601.

14. Survey of Traffic Noise Reduction Products, Materials, and Technologies.

15. Minimal access excision of aortic valve fibroelastoma: a case report and review of the literature

16. Biological conversion assay using Clostridium phytofermentans to estimate plant feedstock quality

17. High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma

18. Effect of pentoxifylline on preventing acute kidney injury after cardiac surgery by measuring urinary neutrophil gelatinase - associated lipocalin

19. READER'S FORUM.

20. The Black Women's Health Study.

21. WAITING FOR MY TINA TURNER CAREER OPPORTUNITY.

22. DIVERSITY: SAME GENDER ISSUES.

23. Welcome to the FY '05 Yearbook!

24. Strong and Vibrant.

25. Looking to the Future.

26. Witamy, Wilkommen, Bienvenido!

27. SWE Successes in FY03.

28. Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial.

29. Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.

30. Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.

31. A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma.

32. HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia.

33. Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients.

34. Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients.

35. Chronic pain in children and adolescents diagnosed with cancer: the challenge of mitigating the pain and the potential of integrating exercise into pain management.

36. A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma.

37. Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Cohort Study.

38. Natural Killer Cell Alloreactivity Predicted By Killer Cell Immunoglobulin-Like Receptor Ligand Mismatch Does Not Impact Engraftment in Umbilical Cord Blood and Haploidentical Stem Cell Transplantation.

39. Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion.

40. A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma.

41. Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1.

42. Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622.

43. Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report.

44. Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research.

45. Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignancies.

46. Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses.

47. Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies.

48. mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia.

49. Targeting Notch signaling in autoimmune and lymphoproliferative disease.

50. Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease.

Catalog

Books, media, physical & digital resources